These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 19920767

  • 21. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice.
    Liu L, Shi R, Shi Q, Cheng Y, Huo Y.
    Planta Med; 2008 Feb; 74(3):203-9. PubMed ID: 18260050
    [Abstract] [Full Text] [Related]

  • 22. Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: possible role in allergic reactions.
    Ware JA, Graf ML, Martin BM, Lustberg LR, Pohl LR.
    Chem Res Toxicol; 1998 Mar; 11(3):164-71. PubMed ID: 9544613
    [Abstract] [Full Text] [Related]

  • 23. Gastroprotection and effect of the simultaneous administration of Cuachalalate (Amphipterygium adstringens) on the pharmacokinetics and anti-inflammatory activity of diclofenac in rats.
    Navarrete A, Oliva I, Sánchez-Mendoza ME, Arrieta J, Cruz-Antonio L, Castañeda-Hernández G.
    J Pharm Pharmacol; 2005 Dec; 57(12):1629-36. PubMed ID: 16354407
    [Abstract] [Full Text] [Related]

  • 24. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
    Fadillioğlu E, Erdoğan H, Söğüt S, Kuku I.
    J Appl Toxicol; 2003 Dec; 23(1):71-4. PubMed ID: 12518339
    [Abstract] [Full Text] [Related]

  • 25. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy.
    Lebrecht D, Setzer B, Ketelsen UP, Haberstroh J, Walker UA.
    Circulation; 2003 Nov 11; 108(19):2423-9. PubMed ID: 14568902
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A comparison of gastrointestinal permeability induced by diclofenac-phospholipid complex with diclofenac acid and its sodium salt.
    Khazaeinia T, Jamali F.
    J Pharm Pharm Sci; 2003 Nov 11; 6(3):352-9. PubMed ID: 14738716
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of methimazole treatment on doxorubicin-induced cardiotoxicity in mice.
    Osman AM, Nemnem MM, Abou-Bakr AA, Nassier OA, Khayyal MT.
    Food Chem Toxicol; 2009 Oct 11; 47(10):2425-30. PubMed ID: 19577608
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
    Martin E, Thougaard AV, Grauslund M, Jensen PB, Bjorkling F, Hasinoff BB, Tjørnelund J, Sehested M, Jensen LH.
    Toxicology; 2009 Jan 08; 255(1-2):72-9. PubMed ID: 19010377
    [Abstract] [Full Text] [Related]

  • 31. Irritation of gastrointestinal mucosa by new glycosyl derivative of diclofenac in comparison with diclofenac in rats.
    Borowiecka J, Pakulska W, Graczyk J, Wagrowska-Danilewicz M.
    Acta Pol Pharm; 2000 Nov 08; 57 Suppl():99-102. PubMed ID: 11293281
    [Abstract] [Full Text] [Related]

  • 32. How to protect doxorubicin-induced cardiomyopathy in male albino rats?
    Shaker O, Sourour DA.
    J Cardiovasc Pharmacol; 2010 Mar 08; 55(3):262-8. PubMed ID: 20051877
    [Abstract] [Full Text] [Related]

  • 33. Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice.
    Riad A, Bien S, Westermann D, Becher PM, Loya K, Landmesser U, Kroemer HK, Schultheiss HP, Tschöpe C.
    Cancer Res; 2009 Jan 15; 69(2):695-9. PubMed ID: 19147586
    [Abstract] [Full Text] [Related]

  • 34. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice.
    Naidu MU, Kumar KV, Mohan IK, Sundaram C, Singh S.
    Indian J Exp Biol; 2002 Aug 15; 40(8):894-900. PubMed ID: 12597018
    [Abstract] [Full Text] [Related]

  • 35. Diclofenac/misoprostol: novel findings and their clinical potential.
    Shield MJ.
    J Rheumatol Suppl; 1998 May 15; 51():31-41. PubMed ID: 9596552
    [Abstract] [Full Text] [Related]

  • 36. Effects of ibuprofen on doxorubicin toxicity.
    Inchiosa MA, Smith CM.
    Res Commun Chem Pathol Pharmacol; 1990 Jan 15; 67(1):63-78. PubMed ID: 2139234
    [Abstract] [Full Text] [Related]

  • 37. [Nonsteroidal antiinflammatory drugs and nitric oxide].
    Kowalczyk E, Kopff A, Błaszczyk J, Kopff M.
    Pol Merkur Lekarski; 2006 Apr 15; 20(118):421-3. PubMed ID: 16886565
    [Abstract] [Full Text] [Related]

  • 38. Hyperbaric oxygen therapy does not potentiate doxorubicin-induced cardiotoxicity in rats.
    Karagoz B, Suleymanoglu S, Uzun G, Bilgi O, Aydinoz S, Haholu A, Turken O, Onem Y, Kandemir EG.
    Basic Clin Pharmacol Toxicol; 2008 Mar 15; 102(3):287-92. PubMed ID: 18248515
    [Abstract] [Full Text] [Related]

  • 39. Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats.
    Funatsu T, Chono K, Hirata T, Keto Y, Kimoto A, Sasamata M.
    Eur J Pharmacol; 2007 Jan 05; 554(1):53-9. PubMed ID: 17112499
    [Abstract] [Full Text] [Related]

  • 40. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.
    Wallace JL, Caliendo G, Santagada V, Cirino G, Fiorucci S.
    Gastroenterology; 2007 Jan 05; 132(1):261-71. PubMed ID: 17241876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.